These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8030696)

  • 1. Cyclic changes in endometrial tissue plasminogen activator and plasminogen activator inhibitor type 1 in women with normal menstruation and essential menorrhagia.
    Gleeson NC
    Am J Obstet Gynecol; 1994 Jul; 171(1):178-83. PubMed ID: 8030696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endometrial fibrinolytic enzymes in women with normal menstruation and dysfunctional uterine bleeding.
    Gleeson N; Devitt M; Sheppard BL; Bonnar J
    Br J Obstet Gynaecol; 1993 Aug; 100(8):768-71. PubMed ID: 8399019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of tranexamic acid on measured menstrual loss and endometrial fibrinolytic enzymes in dysfunctional uterine bleeding.
    Gleeson NC; Buggy F; Sheppard BL; Bonnar J
    Acta Obstet Gynecol Scand; 1994 Mar; 73(3):274-7. PubMed ID: 8122512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of levonorgestrel-releasing intrauterine system use on menstrual blood loss and the hemostatic, fibrinolytic/inhibitor systems in women with menorrhagia.
    Koh SC; Singh K
    J Thromb Haemost; 2007 Jan; 5(1):133-8. PubMed ID: 17010149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes of plasminogen activator in human uterine tissue induced by intrauterine contraceptive devices.
    Shaw ST; Macaulay LK; Sun NC; Tanaka MS; Roche PC
    Contraception; 1983 Feb; 27(2):131-40. PubMed ID: 6682747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No increased systemic fibrinolysis in women with heavy menstrual bleeding.
    Wiewel-Verschueren S; Knol HM; Lisman T; Bogchelman DH; Kluin-Nelemans JC; van der Zee AG; Mulder AB; Meijer K
    J Thromb Haemost; 2014 Sep; 12(9):1488-93. PubMed ID: 24954113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of endometrial plasminogen activator-inhibitor 1: a possible mechanism contributing to the effect of intrauterine levonorgestrel in the treatment of menorrhagia.
    Rutanen E; Hurskainen R; Finne P; Nokelainen K
    Fertil Steril; 2000 May; 73(5):1020-4. PubMed ID: 10785231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor beta1 in the human endometrium. Cyclic variation, increased expression by estradiol and progesterone, and regulation of plasminogen activators and plasminogen activator inhibitor-1.
    Casslén B; Sandberg T; Gustavsson B; Willén R; Nilbert M
    Biol Reprod; 1998 Jun; 58(6):1343-50. PubMed ID: 9623591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concentration of plasminogen activators and inhibitor in the human endometrium at different phases of the menstrual cycle.
    Koh SC; Wong PC; Yuen R; Chua SE; Ng BL; Ratnam SS
    J Reprod Fertil; 1992 Nov; 96(2):407-13. PubMed ID: 1339823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Plasminogen Activator System, Glucocorticoid, and Mineralocorticoid Receptors in the Primate Endometrium During Artificial Menstrual Cycles.
    Demirel E; Sabouni R; Chandra N; Slayden OD; Archer DF
    Reprod Sci; 2022 Mar; 29(3):1001-1019. PubMed ID: 34796470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levonorgestrel-intrauterine system effects on hemostasis and menstrual blood loss in women seeking contraception.
    Koh SC; Singh K
    J Obstet Gynaecol Res; 2010 Aug; 36(4):838-44. PubMed ID: 20666954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The fibrinolytic enzyme system in normal menstruation and excessive uterine bleeding and the effect of tranexamic acid.
    Dockeray CJ; Sheppard BL; Daly L; Bonnar J
    Eur J Obstet Gynecol Reprod Biol; 1987 Apr; 24(4):309-18. PubMed ID: 2953634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential localization and expression of urokinase plasminogen activator (uPA), its receptor (uPAR), and its inhibitor (PAI-1) mRNA and protein in endometrial tissue during the menstrual cycle.
    Nordengren J; Pilka R; Noskova V; Ehinger A; Domanski H; Andersson C; Høyer-Hansen G; Hansson SR; Casslén B
    Mol Hum Reprod; 2004 Sep; 10(9):655-63. PubMed ID: 15243126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies in menorrhagia: (a) mefenamic acid, (b) endometrial prostaglandin concentrations.
    Haynes PJ; Flint AP; Hodgson H; Anderson AB; Dray F; Turnbull AC
    Int J Gynaecol Obstet; 1980; 17(6):567-72. PubMed ID: 6106574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endometrial vascular development in heavy menstrual bleeding: altered spatio-temporal expression of endothelial cell markers and extracellular matrix components.
    Biswas Shivhare S; Bulmer JN; Innes BA; Hapangama DK; Lash GE
    Hum Reprod; 2018 Mar; 33(3):399-410. PubMed ID: 29309596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemostatic status and fibrinolytic response potential at different phases of the menstrual cycle.
    Koh SC; Prasad RN; Fong YF
    Clin Appl Thromb Hemost; 2005 Jul; 11(3):295-301. PubMed ID: 16015415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinolytic activity in utero and bleeding complications with intrauterine contraceptive devices.
    Bonnar J; Kasonde K; Haddon M; Hassanein MK; Allington MJ
    Br J Obstet Gynaecol; 1976 Feb; 83(2):160-4. PubMed ID: 148902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered vascular smooth muscle cell differentiation in the endometrial vasculature in menorrhagia.
    Biswas Shivhare S; Bulmer JN; Innes BA; Hapangama DK; Lash GE
    Hum Reprod; 2014 Sep; 29(9):1884-94. PubMed ID: 25006206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of menstrual cycle on periodontal health and gingival crevicular fluid markers.
    Becerik S; Ozçaka O; Nalbantsoy A; Atilla G; Celec P; Behuliak M; Emingil G
    J Periodontol; 2010 May; 81(5):673-81. PubMed ID: 20218781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasminogen activators in the endometrium. II. Clinical aspects. Variation in the concentration of plasminogen activators during the menstrual cycle and its relation to menstrual blood loss.
    Rybo G
    Acta Obstet Gynecol Scand; 1966; 45(4):429-50. PubMed ID: 5955253
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.